Puglisi, F., Gerratana, L., Lambertini, M., Ceppi, M., Boni, L., Montemurro, F., . . . Del Mastro, L. (2021). Composite risk and benefit from adjuvant dose-dense chemotherapy in hormone receptor-positive breast cancer. NPJ Breast Cancer.
Chicago Style CitationPuglisi, Fabio, et al. "Composite Risk and Benefit From Adjuvant Dose-dense Chemotherapy in Hormone Receptor-positive Breast Cancer." NPJ Breast Cancer 2021.
Cita MLAPuglisi, Fabio, et al. "Composite Risk and Benefit From Adjuvant Dose-dense Chemotherapy in Hormone Receptor-positive Breast Cancer." NPJ Breast Cancer 2021.
Atenció: Aquestes cites poden no estar 100% correctes.